NASDAQ:NDRA - ENDRA Life Sciences Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.54 +0.01 (+0.65 %) (As of 04/24/2019 02:32 PM ET)Previous Close$1.53Today's Range$1.49 - $1.6052-Week Range$1.36 - $5.75Volume69,473 shsAverage Volume307,030 shsMarket Capitalization$10.21 millionP/E RatioN/ADividend YieldN/ABeta0.5 ProfileDiscussionChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. It also offers Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan. Receive NDRA News and Ratings via Email Sign-up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NDRA Previous Symbol CUSIPN/A CIK1681682 Webwww.endrainc.com Phone734-335-0468Debt Debt-to-Equity RatioN/A Current Ratio7.13 Quick Ratio7.07Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$10,000.00 Price / Sales1,021.02 Cash FlowN/A Price / Cash FlowN/A Book Value$0.94 per share Price / Book1.64Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-9,800,000.00 Net MarginsN/A Return on Equity-360.26% Return on Assets-249.53%Miscellaneous Employees11 Outstanding Shares6,630,000Market Cap$10.21 million Next Earnings Date5/21/2019 (Estimated) OptionableNot Optionable ENDRA Life Sciences (NASDAQ:NDRA) Frequently Asked Questions What is ENDRA Life Sciences' stock symbol? ENDRA Life Sciences trades on the NASDAQ under the ticker symbol "NDRA." How were ENDRA Life Sciences' earnings last quarter? ENDRA Life Sciences Inc (NASDAQ:NDRA) released its earnings results on Monday, March, 11th. The company reported ($0.28) EPS for the quarter. View ENDRA Life Sciences' Earnings History. When is ENDRA Life Sciences' next earnings date? ENDRA Life Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, May 21st 2019. View Earnings Estimates for ENDRA Life Sciences. Has ENDRA Life Sciences been receiving favorable news coverage? News articles about NDRA stock have trended very positive recently, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. ENDRA Life Sciences earned a coverage optimism score of 3.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. Who are some of ENDRA Life Sciences' key competitors? Some companies that are related to ENDRA Life Sciences include Viveve Medical (VIVE), Digirad (DRAD), Precision Optics (PEYE), Fc Global Realty (FCRE), Nexeon Medsystems (NXNN), Vaso (VASO), Non-Invasive Monitoring Systems (NIMU), CHF Solutions (CHFS), Aradigm (ARDM), Escalon Medical (ESMC), Reshape Lifesciences (RSLS), Trimedyne (TMED), SpectraScience (SCIE), Guided Therapeutics (GTHP) and Newcardio (NWCI). What other stocks do shareholders of ENDRA Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other ENDRA Life Sciences investors own include Aptose Biosciences (APTO), AcelRx Pharmaceuticals (ACRX), Amarin (AMRN), Atomera (ATOM), Aurinia Pharmaceuticals (AUPH), AzurRx BioPharma (AZRX), Crispr Therapeutics (CRSP), Eiger Biopharmaceuticals (EIGR), Genocea Biosciences (GNCA) and Inovio Pharmaceuticals (INO). Who are ENDRA Life Sciences' key executives? ENDRA Life Sciences' management team includes the folowing people: Mr. Francois Michelon, Chairman & CEO (Age 53)Mr. David R. Wells, Chief Financial Officer (Age 57)Mr. Michael Thornton, Chief Technology Officer (Age 51)Dr. Jonathan Behr Ph.D., Co-FounderMr. Steve Freeman, HR Leader When did ENDRA Life Sciences IPO? (NDRA) raised $10 million in an initial public offering on Friday, February 3rd 2017. The company issued 2,000,000 shares at $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities served as the underwriters for the IPO. Who are ENDRA Life Sciences' major shareholders? ENDRA Life Sciences' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.43%). View Institutional Ownership Trends for ENDRA Life Sciences. Which major investors are buying ENDRA Life Sciences stock? NDRA stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC. View Insider Buying and Selling for ENDRA Life Sciences. How do I buy shares of ENDRA Life Sciences? Shares of NDRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is ENDRA Life Sciences' stock price today? One share of NDRA stock can currently be purchased for approximately $1.50. How big of a company is ENDRA Life Sciences? ENDRA Life Sciences has a market capitalization of $9.95 million and generates $10,000.00 in revenue each year. ENDRA Life Sciences employs 11 workers across the globe. What is ENDRA Life Sciences' official website? The official website for ENDRA Life Sciences is http://www.endrainc.com. How can I contact ENDRA Life Sciences? ENDRA Life Sciences' mailing address is 3600 GREEN COURT SUITE 350, ANN ARBOR MI, 48105. The company can be reached via phone at 734-335-0468 or via email at [email protected] MarketBeat Community Rating for ENDRA Life Sciences (NASDAQ NDRA)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 125 (Vote Outperform)Underperform Votes: 153 (Vote Underperform)Total Votes: 278MarketBeat's community ratings are surveys of what our community members think about ENDRA Life Sciences and other stocks. Vote "Outperform" if you believe NDRA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NDRA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/24/2019 by MarketBeat.com StaffFeatured Article: How does the Federal Reserve determine interest rates?